| 000 | 01818 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250514025609.0 | ||
| 264 | 0 | _c20020513 | |
| 008 | 200205s 0 0 eng d | ||
| 022 | _a0006-3223 | ||
| 024 | 7 |
_a10.1016/s0006-3223(01)01342-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFriedman, Joseph I | |
| 245 | 0 | 0 |
_aA double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia. _h[electronic resource] |
| 260 |
_bBiological psychiatry _cMar 2002 |
||
| 300 |
_a349-57 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCognition Disorders _xdiagnosis |
| 650 | 0 | 4 | _aDonepezil |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndans _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeuropsychological Tests |
| 650 | 0 | 4 |
_aPiperidines _xadministration & dosage |
| 650 | 0 | 4 |
_aRisperidone _xadministration & dosage |
| 650 | 0 | 4 |
_aSchizophrenia _xdiagnosis |
| 650 | 0 | 4 | _aSchizophrenic Psychology |
| 700 | 1 | _aAdler, David N | |
| 700 | 1 | _aHowanitz, Evelyn | |
| 700 | 1 | _aHarvey, Philip D | |
| 700 | 1 | _aBrenner, Grant | |
| 700 | 1 | _aTemporini, Humberto | |
| 700 | 1 | _aWhite, Leonard | |
| 700 | 1 | _aParrella, Michael | |
| 700 | 1 | _aDavis, Kenneth L | |
| 773 | 0 |
_tBiological psychiatry _gvol. 51 _gno. 5 _gp. 349-57 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0006-3223(01)01342-7 _zAvailable from publisher's website |
| 999 |
_c11809900 _d11809900 |
||